Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mini Rev Med Chem. 2005 Sep;5(9):791-804.

BX471: a CCR1 antagonist with anti-inflammatory activity in man.

Author information

  • 1Department of Immunology, Berlex Biosciences, Richmond, CA 94804, USA. Richard_Horuk@Berlex.com.

Abstract

Chemokines belong to a large family of chemoattractant molecules involved in the directed migration of immune cells. They achieve their cellular effects by direct interaction with cell surface receptors. The chemokine receptor CCR1 appears to be involved in a variety of proinflammatory and autoimmune diseases and this makes it a very attractive therapeutic target. This review discusses the identification, chemistry, biology and therapeutic potential of BX 471 a potent CCR1 antagonist that is currently in the clinic for a variety of indications.

PMID:
16178722
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Write to the Help Desk